Hot Life Science Investor Mandate 1: Multinational VC Fund Seeks Breakthrough Biopharmaceuticals

15 Oct

A venture capital firm founded in 2012 with offices in Eastern and Western US and Ireland is currently looking to make new investments into biopharmaceutical and medical device companies from its $172 million fund. The firm looks to invest in companies in seed to series B rounds and can provide up to about $17 million to a company over the lifetime of the investment. The firm is most interested in companies based in the US, Canada, and Ireland and will also consider exceptional opportunities elsewhere in Europe and in Asia. The firm plans to make approximately 4-5 new investments over the next 6-9 months.

The firm is interested in companies developing either biopharmaceuticals or medical devices. For biopharmaceuticals, the firm is interested in all modalities including small molecules, biologics, and cell and gene therapies. The firm is primarily interested in platform companies with the potential for multiple assets and strongly prefers technologies to be 1st in class or best in class, often originating from breakthrough chemistry or biology discoveries. The firm is looking for companies with assets in preclinical development through Phase 1 clinical trials. For medical devices, the firm is primarily interested in companies working on devices that are therapeutic in nature, as well as devices for self-pay markets, including aesthetics. The firm is indication-agnostic in both biopharmaceuticals and devices.

The firm can both lead and co-lead investments, with a preference for taking a board seat. The firm prefers working with management teams with positive track records; however, they are open to working with incomplete or non-permanent management teams as well, especially for very early stage opportunities. The firm’s team has extensive operating experience and deep networks, which they can leverage to support companies as needed.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: